SENORES PHARMACEUTICALS L (SENORES) Share Price Hits Fresh 52-Week High

SENORES PHARMACEUTICALS L Share Price rose to Rs 1,570.75, up 2.13% today, after touching a fresh 52-week high of Rs 1,576. Market capitalisation stood at Rs 7,121.5 crore.

SENORES PHARMACEUTICALS L Share Price was at Rs 1,570.75 on 19 August 2026 at 11:41 AM IST, up Rs 32.75 or 2.13% from the previous close of Rs 1,538, after touching a fresh 52-week high of Rs 1,576. With a market capitalisation of Rs 7,121.5 crore, the stock has moved into focus in today’s Stock Market Today screens as investors track fresh yearly highs and market movers across the Indian Stock Market.

The verified data confirms the price event clearly: SENORES opened at Rs 1,530, slipped to an intraday low of Rs 1,527.1, and then climbed to its one-year high of Rs 1,576. Turnover stood at Rs 1.05 crore with 6,703 shares traded. That combination makes this SENORES PHARMACEUTICALS L Share Price Today move notable because the stock not only advanced on the day but also reset its 52-week peak during active intraday price action.

What the supplied data does not establish is a company-specific catalyst. So, in this SENORES PHARMACEUTICALS L Stock News update, the most reliable conclusion is that the market is reacting to price strength visible in the trading session itself. For investors following 52 Week High Stocks, Univest notes that the next step is to assess whether valuation, profitability metrics, sector positioning and peer comparisons support continued attention to the stock.

SENORES PHARMACEUTICALS L Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,570.75
Previous Close	Rs 1,538
Today's Change	+Rs 32.75 (+2.13%)
Day Open	Rs 1,530
Fresh 52-Week High	Rs 1,576
Day Low	Rs 1,527.1
Current Volume	6,703
Turnover	Rs 1.05 crore
Market Capitalisation	Rs 7,121.5 crore

SENORES PHARMACEUTICALS L (SENORES) traded at Rs 1,570.75. versus the previous close of Rs 1,538, a rise of 2.13%. The stock opened at Rs 1,530, reached Rs 1,576, touched Rs 1,527.1. Reported volume was 6,703.

SENORES PHARMACEUTICALS L Share Price Today showed a clear intraday expansion from the opening level to a fresh 52-week high, with the stock holding most of its gains near the upper end of the day’s range. The session reflects positive price action, while turnover and traded volume show how much participation accompanied the move.

SENORES PHARMACEUTICALS L Share Price opened at Rs 1,530 versus the previous close of Rs 1,538, indicating a slightly softer start. However, the stock then moved up through the session, touched Rs 1,576 as a fresh 52-week high, and traded at Rs 1,570.75 at the time captured in the supplied data. The day low of Rs 1,527.1 means the stock recovered sharply from the lower end of the intraday range and remained just Rs 5.25 below the session high.

The absolute gain of Rs 32.75 and the 2.13% rise place the counter among Stocks in News for the session, especially because the move coincided with a new one-year high rather than a routine intraday bounce. Turnover of Rs 1.05 crore and current volume of 6,703 shares show that the price move was backed by actual trading activity, even though the supplied data does not include an average volume baseline for a deeper Volume Analysis comparison.

For readers searching SENORES PHARMACEUTICALS L Share Price Live, the main takeaway is straightforward: the stock established a fresh yearly high during the session and stayed close to that level. From a market-structure perspective, that keeps attention on whether the current Market Update is being supported by fundamentals and relative valuation.

SENORES PHARMACEUTICALS L (SENORES) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 7,121.5 crore
P/E Ratio	51.17x
P/B Ratio	2.03x
ROE	-0.78%
ROCE	8.31%

SENORES PHARMACEUTICALS L was valued at a P/E ratio of 51.17x, a P/B ratio of 2.03x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of -0.78% and ROCE of 8.31%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Company P/E Ratio	51.17x
Benchmark Median P/E	20.79x
Benchmark Average P/E	47.16x
Benchmark P/E Range	0x to 1,635.98x
Company P/B Ratio	2.03x
Benchmark Median P/B	1.9x
Company ROE	-0.78%
Benchmark Median ROE	11.09%
Company ROCE	8.31%
Benchmark Median ROCE	13.29%
Company Market Capitalisation	Rs 7,121.5 crore
Benchmark Median Market Cap	Rs 134.22 crore

SENORES PHARMACEUTICALS L (SENORES) is classified under sector: Healthcare.

SENORES PHARMACEUTICALS L (SENORES) has a P/E ratio of 51.17x, which is above the benchmark median of 20.79x, a difference of +146.13%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

SENORES PHARMACEUTICALS L (SENORES) has a ROE of -0.78%, which is below the benchmark median of 11.09%, a difference of -107.03%. SENORES PHARMACEUTICALS L (SENORES) has a ROCE of 8.31%, which is below the benchmark median of 13.29%, a difference of -37.47%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Ind-Swift Laboratories Ltd.	INDSWFTLAB	2,724.51	51.17	2.03	-0.78	8.31
Beta Drugs Ltd.	BETA	2,697.08	62.93	9.96	18.65	22.17
Dr Agarwals Eye Hospital Ltd.	DRAGARWQ	2,583.65	33.9	6.99	36.29	42.4
Sai Parenteral's Ltd.	SAIPARENT	2,431.62	167.79	3.07	13.9	12.97
Fredun Pharmaceuticals Ltd.	FREDUN	2,403.56	54.45	8.13	11.42	13.15

SENORES PHARMACEUTICALS L (SENORES) has a P/E ratio of 51.17x compared with the displayed peer median of 54.45x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -0.78% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at 8.31% versus the displayed peer median of 13.15%, providing a capital-efficiency comparison. SENORES PHARMACEUTICALS L (SENORES) has a market capitalisation of Rs 7,121.5 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

Why Investors Are Watching SENORES PHARMACEUTICALS L

The stock is drawing attention because the verified data combines a fresh yearly high with a distinct valuation and sector-positioning profile. For investors scanning Breakout Stocks and 52 Week High screens, these are the factual points being watched on Univest.

• Fresh 52-week high: The stock touched Rs 1,576, marking a new one-year high during the session.
• Positive daily move: The price was up Rs 32.75 or 2.13% versus the previous close of Rs 1,538.
• Intraday resilience: After opening at Rs 1,530 and dipping to Rs 1,527.1, the stock rebounded strongly toward the day high.
• Size and visibility: Market capitalisation of Rs 7,121.5 crore makes it meaningful within the listed Healthcare space.
• Valuation context: P/E of 51.17 is above the sector median of 20.79 and average of 47.16, while P/B of 2.03 is closer to benchmark norms.
• Profitability watchpoint: ROE of -0.78% and ROCE of 8.31% are below the same-sector medians of 11.09% and 13.29%.
• Peer positioning: The company’s market cap is larger than the supplied peer set, but profitability ratios trail most of those comparables.

About SENORES PHARMACEUTICALS L

SENORES PHARMACEUTICALS L is a listed company tracked under the Healthcare sector in the supplied Univest dataset. The available data does not provide a detailed segment breakdown, revenue mix or product-level business profile, but the company name and market classification place it within the broader healthcare ecosystem that investors often monitor through NSE News, BSE News and sector-based stock screens.

In the current market context, the company is being watched primarily through its stock performance rather than a disclosed event-specific operational update. Its market capitalisation of Rs 7,121.5 crore makes it a meaningful listed name relative to the supplied same-sector benchmark universe. For readers following SENORES PHARMACEUTICALS L Latest News, the current discussion is centred on price action, valuation multiples, sector comparison and peer metrics, all of which help frame where the stock sits within the broader Healthcare space.

Track SENORES PHARMACEUTICALS L Share Price on Univest

Use SENORES PHARMACEUTICALS L (SENORES) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Investors tracking SENORES PHARMACEUTICALS L Share Price can use Univest to follow live share price moves, 52-week levels, market capitalisation, valuation ratios, peer comparison and broader stock analysis in one place. Univest also helps users monitor how a stock’s Market Cap, P/E, P/B, ROE and ROCE compare with the wider sector and other listed peers.

For users searching SENORES PHARMACEUTICALS L Share Price Today or SENORES PHARMACEUTICALS L Company News, the key advantage is structured monitoring. A fresh 52-week high often increases visibility, but ongoing analysis requires more than price alone. On Univest, investors can track price action, fundamental analysis, sector context and market insights as the stock continues to feature in market news and stock updates.

Frequently Asked Questions

What is the latest SENORES PHARMACEUTICALS L Share Price Today?

Ans. SENORES PHARMACEUTICALS L Share Price Today was Rs 1,570.75 at the captured time on 19 August 2026. The stock was up Rs 32.75, or 2.13%, from the previous close of Rs 1,538.

Did SENORES PHARMACEUTICALS L hit a fresh 52-week high today?

Ans. Yes, the stock touched Rs 1,576 in intraday trade, marking a fresh 52-week high. It later traded at Rs 1,570.75, staying close to the day’s peak and keeping the one-year high event in focus.

Why is SENORES PHARMACEUTICALS L Share Price rising today?

Ans. The supplied data confirms that the stock rose 2.13% and reached a fresh 52-week high today. However, the verified figures establish the price event itself and do not identify a separate company-specific catalyst for the move.

What were the day high, day low and opening price of SENORES PHARMACEUTICALS L?

Ans. SENORES opened at Rs 1,530, touched a day low of Rs 1,527.1 and rose to a day high of Rs 1,576. This intraday range shows the stock recovered from an early dip and moved strongly higher.

What is the market capitalisation of SENORES PHARMACEUTICALS L?

Ans. The market capitalisation of SENORES PHARMACEUTICALS L stood at Rs 7,121.5 crore in the supplied data. That is well above the Healthcare sector benchmark median of Rs 134.22 crore and average of Rs 465.93 crore.

How is SENORES PHARMACEUTICALS L valued on P/E and P/B?

Ans. The stock traded at a P/E ratio of 51.17 and a P/B ratio of 2.03. Its P/E is above the sector median of 20.79 and average of 47.16, while P/B is near the benchmark median.

How do SENORES PHARMACEUTICALS L ROE and ROCE compare with the sector?

Ans. SENORES reported ROE of -0.78% and ROCE of 8.31%. Both are below the Healthcare sector median figures of 11.09% and 13.29%, and also below the sector averages of 15.58% and 17.78%.

How much volume and turnover were recorded in SENORES PHARMACEUTICALS L today?

Ans. The stock recorded current volume of 6,703 shares and turnover of Rs 1.05 crore in the supplied session snapshot. These figures show that the fresh 52-week high was accompanied by measurable trading activity.

How does SENORES PHARMACEUTICALS L compare with its peers?

Ans. SENORES had the largest market capitalisation among the supplied peers at Rs 7,121.5 crore. Its P/E of 51.17 was mid-range, but its ROE of -0.78% and ROCE of 8.31% trailed most peer figures.

Where can investors track SENORES PHARMACEUTICALS L Share Price and stock analysis?

Ans. Investors can track SENORES PHARMACEUTICALS L Share Price on Univest for live price updates, 52-week levels, market capitalisation, valuation ratios, peer comparison and broader market insights linked to the stock’s current trading position.